MariMed Promotes Ryan Crandall to Chief Commercial Officer
'Ryan has been a driving force behind creating our innovative and trusted portfolio of brands and establishing them as top sellers in our core markets,' said Mr. Levine. 'He has also guided our efforts to deliver an exceptional customer experience at our retail locations. His promotion to Chief Commercial Officer is well-deserved and I look forward to his continued contributions to value generation for our customers and shareholders.'
Mr. Crandall entered the cannabis industry in 2014 when he co-created Betty's Eddies™, a brand of all-natural, cannabis-infused chews that MariMed acquired prior to his joining the company in 2018. Prior, he held a series of executive positions with increasing sales responsibilities in major cybersecurity and software corporations, including RSA Security and EMC2.
'I am honored and excited to step into the role of Chief Commercial Officer at MariMed,' said Mr. Crandall. 'Being a part of this great company, with its award-winning brands, dedication to strategic growth initiatives, and commitment to its mission of improving lives, has been a fantastic journey. I'm eager to deepen my collaboration with our talented team, building on our collective success to strengthen MariMed's position as a leading cannabis products company.'
About MariMedMariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby's Baked™, InHouse™, Nature's Heritage™, and Vibations™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit www.marimedinc.com.
Company Contact:Howard SchacterChief Communications Officer Email: hschacter@marimedinc.comPhone: (781) 277-0007
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
40 minutes ago
- Business Upturn
Coloplast A/S – Interim Financial Report, 9M 2024/25
By GlobeNewswire Published on August 19, 2025, 10:33 IST 2024/25 Interim financial results, 9M 2024/25 1 October 2024 – 30 June 2025 Coloplast delivered organic growth of 7% and an EBIT margin1 of 28% in Q3. Reported revenue in DKK grew 1% with negative impact from currencies and the Skin Care divestment. Organic growth rates by business area: Ostomy Care 6%, Continence Care 8%, Voice and Respiratory Care 9%, Advanced Wound Care 4% and Interventional Urology 4%. Growth in Ostomy Care was driven by broad-based contribution across regions, except for China which delivered low-single digit growth, as expected. Growth in Continence Care was driven by continued strong contribution from the Luja™ portfolio. Voice and Respiratory Care growth was driven by continued good momentum in both Laryngectomy and Tracheostomy. Growth in Advanced Wound Dressings was -2%, driven primarily by a significant decline in China which was impacted by a preventative and voluntary product return of all Biatain® Adhesive foam dressings in the market. The product return is expected to have a negative revenue impact of around DKK 80 million in H2, of which around DKK 20 million impacted Q3. Kerecis grew 17%, with a 13% EBIT margin before PPA amortisation. Growth in the quarter was impacted by a slowdown in the out-patient setting due to the LCD postponement in April, causing a temporary market shift to high-priced products. Growth momentum in Q4 is expected to improve, with a good start to the quarter in July. Growth in Interventional Urology was driven by good momentum in the US Men's Health business, partly offset by continued negative impact from the product recall in Bladder Health and Surgery of around DKK -10 million in Q3. EBIT 1 was DKK 1,915 million, a 2% increase from last year. The EBIT margin 1,2 was 28%, against 27% last year. was DKK 1,915 million, a 2% increase from last year. The EBIT margin was 28%, against 27% last year. Changes to the Executive Leadership Team announced, to support the successful execution of the new company strategy towards 2030. 9M 2024/25 organic growth of 7% and EBIT margin1 of 27%. Reported revenue in DKK grew 4% to DKK 20,914 million. Organic growth rates by business area: Ostomy Care 6%, Continence Care 8%, Voice and Respiratory Care 9%, Advanced Wound Care 9% and Interventional Urology 1%. EBIT 1 was DKK 5,718 million, a 4% increase from last year. The EBIT margin 1 was 27%, on par with last year 2 . was DKK 5,718 million, a 4% increase from last year. The EBIT margin was 27%, on par with last year . Adjusted3 net profit before special items was DKK 3,778 million, a DKK 15 million decrease from last year, negatively impacted by non-cash effect from net financial expenses. Adjusted3 diluted earnings per share (EPS) before special items decreased by 1% to DKK 16.76. Adjusted3 ROIC after tax before special items was 15%, on par with last year. FY 2024/25 guidance is unchanged with organic growth of around 7% and an EBIT margin before special items of 27-28%. Organic growth now includes the negative impact from the product return in Advanced Wound Dressings in China, partly offset by good momentum in the other business areas. Reported growth in DKK is now expected to be 3-4%, with around 2%-points negative impact from currencies and around 1.5%-points negative impact from the Skin Care divestment. The assumptions on the reported EBIT margin before special items are largely unchanged. Special items expectations are unchanged, around DKK 450 million. Expectations on capital expenditures and tax rate (ordinary and effective) are also unchanged. 'We deliver a third quarter as expected with 7% organic growth and an EBIT margin of 28%, maintaining our financial guidance for 2024/25. Our Q3 performance was driven by broad-based growth across our chronic care businesses, offsetting the challenges in China. I'm pleased to see the global Coloplast organisation continuing to deliver on our priorities and moving the business forward. The search for Coloplast's new CEO remains on track. I look forward to presenting our 2030 strategy at our Capital Markets Day on 2 September alongside the new Executive Leadership Team, announced today,' says interim CEO Lars Rasmussen. 1. before special items expenses of DKK 83 million in Q3 2024/25 and DKK 241 million in 9M 2024/25. 2. before special items expenses of DKK 36 million in Q3 2023/24 and DKK 70 million in 9M 2023/24. 3. Adjusted for the impact from the Kerecis IP transfer. Conference call Coloplast will host a conference call on Tuesday, 19 August 2025 at 11.00 CEST. The call is expected to last about one actively participate in the Q&A session please sign up ahead of the conference call on the link here to receive an e-mail with dial-in details: Register here Access the conference call webcast directly here: Coloplast – 9M 2024/25 conference call For further information, please contact Investors and analysts Anders Lonning-SkovgaardExecutive Vice President, CFO Tel. +45 4911 1111 Aleksandra DimovskaVice President, Investor RelationsTel. +45 4911 1800 / +45 4911 2458 Email: [email protected] Kristine Husted MunkSenior Manager, Investor RelationsTel. +45 4911 1800 / +45 4911 3266 Email: [email protected] Simone Dyrby HelvindSenior Manager, Investor RelationsTel. +45 4911 1800 / +45 4911 2981 Email: [email protected] Press and media Peter MønsterSr. Media Relations ManagerTel. +45 4911 2623 Email: [email protected] Address Coloplast A/SHoltedam 1DK-3050 HumlebaekDenmark Company reg. (CVR) no. 69749917 Website This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail. Coloplast was founded on passion, ambition, and commitment. We were born from a nurse's wish to help her sister and the skills of an engineer. Guided by empathy, our mission is to make life easier for people with intimate healthcare needs. Over decades, we have helped millions of people to live a more independent life and we continue to do so through innovative products and services. Globally, our business areas include Ostomy Care, Continence Care, Advanced Wound Care, Interventional Urology and Voice and Respiratory Care. The Coloplast logo is a registered trademark of Coloplast A/S. © 2025-08. All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark. Attachment 06_2025_9M_2024_25_Earnings_release Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Business Upturn
44 minutes ago
- Business Upturn
Navatar Unveils AI-Powered CRM That Meets M&A Advisors Where They Work From Outlook to Slack to CRM: Investment Banking's First Truly Embedded Intelligence Platform For Salesforce
By GlobeNewswire Published on August 19, 2025, 10:28 IST LONDON and NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) — Navatar, the leading platform for private markets, today announced the launch of its next-generation, fully AI-powered CRM purpose-built for M&A advisory firms. The new platform combines intelligence, automation, and usability—solving one of the biggest challenges firms face when trying to put AI to work: data. A recent Business Insider article warned: 'AI intensifies data flaws rather than solving them,' noting that data is one of the top reasons AI projects fail. For many advisory firms, legacy CRMs have made that problem worse—requiring tedious data entry that bankers inevitably avoid. As a result, most of the useful intelligence remains trapped in inboxes, documents and individual banker memory. Navatar solves this by automatically capturing and structuring activity from emails, call notes, LinkedIn, Slack, documents, public domain and third-party data—including relevant benchmarks, market comps, and triggers from the public internet—turning your team's daily activity into structured, usable intelligence for AI to operate on—turning your team's daily activity into structured, usable intelligence for AI to operate on. AI Where You Work: Inside Outlook, Navatar, or Slack Navatar combines the best of Salesforce AI (Agentforce 3)and Microsoft Copilot so dealmakers no longer need to log into a CRM to get intelligence. Whether working inside Outlook, Navatar or Slack, users receive real-time insights, recommendations, and automation—all natively delivered in the tools they already use. Leveraging Salesforce's Agentforce, Navatar ensures that all proprietary client and deal information remains private and compliant, never shared with or exposed to public AI models. Firms get the power of generative AI with the security of an enterprise-grade, private data environment. Within Microsoft Outlook Smart Contact Insights – See who knows the contact, related mandates, and past interactions directly in your inbox. – See who knows the contact, related mandates, and past interactions directly in your inbox. Email Summarization & Next Steps – AI condenses long threads and suggests follow-ups, tasks, and next steps. – AI condenses long threads and suggests follow-ups, tasks, and next steps. Deal Context at a Glance – View associated mandates, stage, and buyer/seller lists without logging in. – View associated mandates, stage, and buyer/seller lists without logging in. Automated Meeting Prep – Get AI-generated briefs from emails, calendar events, and CRM activity. – Get AI-generated briefs from emails, calendar events, and CRM activity. Activity Capture – Sync emails, calendar and meetings to the right deals and clients automatically. Within Navatar Thematic Sourcing – Identify sectors and companies likely to transact by analyzing market signals, including public news, filings, and web-based benchmarks. – Identify sectors and companies likely to transact by analyzing market signals, including public news, filings, and web-based benchmarks. Buyer/Seller Matching – Predict the most likely matches based on past transactions and strategic fit. – Predict the most likely matches based on past transactions and strategic fit. Relationship Intelligence : Auto-map referral paths, warm intros, and deal team connectivity using AI across your team's network. : Auto-map referral paths, warm intros, and deal team connectivity using AI across your team's network. Document Intelligence – Extract key terms, risks, and data from documents and models. – Extract key terms, risks, and data from documents and models. Pipeline Intelligence – Generate AI summaries for pipeline reporting. – Generate AI summaries for pipeline reporting. Task Automation – Auto-create follow-ups based on conversation or document triggers. Within Slack CRM Alerts in Slack – Get real-time updates on mandates, buyer interest, and client activity. – Get real-time updates on mandates, buyer interest, and client activity. Conversation Linking – Tag Slack threads to deals, clients, or contacts. – Tag Slack threads to deals, clients, or contacts. AI Channel Summaries – Capture highlights and actions from busy deal channels. – Capture highlights and actions from busy deal channels. Push to CRM – Log notes or tasks in Navatar directly from Slack. AI Use Cases for M&A Advisory Firms Navatar's AI transforms every stage of the advisory workflow: Deal Origination – Thematic sourcing, buyer/seller matching, relationship mapping, competitive intelligence. – Thematic sourcing, buyer/seller matching, relationship mapping, competitive intelligence. Pitching – AI-generated buyer lists, pitch deck content, market comps, and tailored sector heatmaps. – AI-generated buyer lists, pitch deck content, market comps, and tailored sector heatmaps. Execution – Document review, data room analysis, call summaries, buyer engagement scoring. – Document review, data room analysis, call summaries, buyer engagement scoring. Client Coverage – Contact enrichment, coverage risk alerts, cross-sell opportunity detection. – Contact enrichment, coverage risk alerts, cross-sell opportunity detection. Market Intelligence – Real-time alerts, comps/multiples tracking, buyer watchlists. – Real-time alerts, comps/multiples tracking, buyer watchlists. Workflow Automation – Automatic activity logging, task creation, and compliance trails. About Navatar Navatar (@navatargroup) powers leading investment banks, M&A advisory firms, and alternative asset managers with cloud CRM solutions purpose-built for private markets. Now fully AI-powered, Navatar captures intelligence automatically and delivers insights directly into Outlook, Slack, and CRM—turning every interaction into firmwide knowledge. Built on Salesforce and integrated with Microsoft Copilot, Navatar eliminates manual data entry, unifies relationship context, and orchestrates complex deal processes—without disrupting how bankers work. Backed by over two decades of CRM expertise, Navatar is used by hundreds of global firms to win more mandates, deepen coverage, and execute faster. For more information, visit Sales TeamNavatar [email protected] Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Business Wire
5 hours ago
- Business Wire
Technologent Partners with ITOCHU Techno-Solutions Corporation to Launch StageCrew in North America
IRVINE, Calif.--(BUSINESS WIRE)--StageCrew™ (Stage Crew), a cloud service that streamlines information collection and coordination in system operations and strengthens observability, will be provided in SaaS format by Technologent. This marks the first full-scale deployment in the United States of a Japan-developed cloud service independently created by ITOCHU Techno-Solutions Corporation. 'In Technologent, we have found a partner that not only shares this forward-looking perspective but has the proven capability to guide enterprises on their digital transformation journeys." 'We're thrilled to bring StageCrew to our customers as the North American service provider as part of our commitment to AI enabling our customers,' said Mike McLaughlin, CIO and Sr. Vice President of Professional Services at Technologent. 'By combining Technologent's deep expertise with StageCrew's AI-powered operational intelligence, we're not just solving problems—we're redefining how enterprises manage complexity and stay ahead of disruption.' "Our vision for StageCrew has always been to create an AI-transformed experience that moves IT operations from being reactive to proactive. A vision this ambitious cannot be realized alone,' said Nagaki Fujioka, Managing Executive Officer and COO, Digital Services Group, at ITOCHU Techno-Solutions Corporation. 'In Technologent, we have found a partner that not only shares this forward-looking perspective but has the proven capability to guide enterprises on their digital transformation journeys. Together, ITOCHU Techno-Solutions Corporation and Technologent are not simply selling software; we are building a new operational standard, powered by Multimodal AI and delivered through a partnership committed to tangible, transformative results for every client," continued Fujioka. Market Background In recent years, the need for accurate real-time system monitoring to ensure stable operations has increased significantly. However, using multiple tools for monitoring across many technology services, log collection and cross-discipline assessments has created significant challenges. These include time and labor-intensive coordination between departments and difficulties in aggregation and consolidation of information. This often complicates the identification of issues, root causes as well as establishing corrective action. In North America, the growing complexity of systems, driven by advancements in cloud-native solutions and microservices technologies, has heightened the demand for solutions that improve efficiency, reduce time-to-resolution and decrease manual effort. About StageCrew StageCrew is a cloud-based service developed by ITOCHU Techno-Solutions Corporation designed to enhance visibility and efficiency in system operations. It improves observability (the ability to monitor and understand system health) by integrating with a wide range of monitoring and log collection tools, providing a unified view of critical data across complex IT environments. By consolidating information and standardizing how incidents are handled, StageCrew helps IT teams respond to issues swiftly and consistently, ultimately improving service reliability. StageCrew empowers IT operations with a scalable, AI-enhanced platform that not only streamlines incident management but also promotes a culture of proactive monitoring and continuous improvement. In summary, StageCrew helps organizations run more resilient, observable, and efficient IT systems – ensuring that technology teams can respond faster, work smarter, and deliver more reliable services to the enterprise. Service Implementation Technologent will provide StageCrew in a SaaS model for the North American market delivered from a dedicated cloud infrastructure. Comprehensive support will be provided from pre-implementation consulting to design, PoC (Proof of Concept), and post-implementation support services to meet North American customer needs. Additional service and product engineering support will be provided to Technologent from ITOCHU Techno-Solutions Corporation, Japan. About Technologent Technologent is a women-owned, WBENC-certified and global provider of Information Technology solutions and services for Fortune 1000 companies. With our internationally recognized technical and sales team and well-established partnerships between the most cutting-edge technology brands, Technologent powers your business through a combination of foundational IT disciplines: Data, Security, Cloud and Artificial Intelligence. Together with Service Provider Solutions, Financial Services, Professional Services and our people, we're paving the way for your business operations with advanced problem-solving that isn't just reactive, but forward-thinking and future-proof. Technologent is a trademark of Thomas Gallaway Company, LLC dba Technologent in the United States and other jurisdictions.
